Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| AU565 | Alvocidib | 0.01 | 0.8458 | -0.01670 |
| AU565 | Alvocidib | 0.031622777 | 0.6891 | -0.00680 |
| AU565 | Alvocidib | 0.031622777 | 0.8563 | 0.02293 |
| AU565 | Alvocidib | 0.031622777 | 0.9241 | 0.00111 |
| AU565 | Alvocidib | 0.1 | 0.3386 | 0.04951 |
| AU565 | Alvocidib | 0.1 | 0.4718 | 0.02100 |
| AU565 | Alvocidib | 0.1 | 0.5876 | 0.01768 |
| AU565 | Alvocidib | 0.316227766 | -0.1583 | 0.22499 |
| AU565 | Alvocidib | 0.316227766 | -0.1362 | 0.17550 |
| AU565 | Alvocidib | 0.316227766 | -0.1881 | 0.23230 |
| AU565 | Alvocidib | 1.0 | -0.6000 | 0.41960 |
| AU565 | Alvocidib | 1.0 | -0.5107 | 0.30546 |
| AU565 | Alvocidib | 1.0 | -0.5502 | 0.42491 |
| AU565 | GSK2334470 | 0.001 | 0.9132 | -0.00799 |
| AU565 | GSK2334470 | 0.001 | 0.9464 | -0.01034 |
| AU565 | GSK2334470 | 0.001 | 1.0502 | 0.00367 |
| AU565 | GSK2334470 | 0.003162278 | 0.8464 | 0.00106 |
| AU565 | GSK2334470 | 0.003162278 | 0.8190 | 0.00869 |
| AU565 | GSK2334470 | 0.003162278 | 0.9290 | -0.00561 |
| AU565 | GSK2334470 | 0.01 | 0.8594 | -0.00239 |
| AU565 | GSK2334470 | 0.01 | 0.6950 | 0.01354 |
| AU565 | GSK2334470 | 0.01 | 0.7442 | -0.00195 |
| AU565 | GSK2334470 | 0.031622777 | 0.9169 | -0.00192 |
| AU565 | GSK2334470 | 0.031622777 | 0.9253 | 0.00801 |
| AU565 | GSK2334470 | 0.031622777 | 0.7404 | 0.00750 |